Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
4.500
-1.365 (-23.27%)
Aug 3, 2026, 12:54 PM EDT - Market open
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$27,714
Profits / Employee
-$1,104,575
Market Cap
7.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Senti Biosciences Holdings | 39 |
| Lunai Bioworks | 29 |
| Curis | 24 |
| BioCardia | 21 |
| Lisata Therapeutics | 21 |
| IN8bio | 18 |
| Theriva Biologics | 16 |
LEXX News
- 3 hours ago - Lexaria Bioscience Corp trading resumes - TheFly
- 3 hours ago - Lexaria Bioscience Corp trading halted, volatility trading pause - TheFly
- 2 days ago - Lexaria Bioscience Corp trading halted, news pending - TheFly
- 4 days ago - Lexaria Bioscience announces effective date for reverse stock split - TheFly
- 4 days ago - Lexaria Announces Effective Date for Reverse Stock Split - Accesswire
- 21 days ago - Lexaria Bioscience Quarterly report: Q3 2026 - Filings
- 4 weeks ago - Lexaria Updates Business Development - TheNewswire
- 5 weeks ago - Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing - TheFly